Patient Rating:

4.6 out of 5

36 Patient Ratings
6 Patient Comments

Josef Stehlik, M.D., M.P.H.

Patient Rating:

4.6 out of 5

36 Patient Ratings
6 Patient Comments

Specialties

Languages

  • Czech
  • English
  • Russian
  • Spanish

Clinical Details

Schedule An Appointment Clinical Office Address
(800) 332-7156 Billings Clinic
1020 North 27th Street
Billings, MT 59107
(208) 367-4278 Saint Alphonsus Regional Medical Center
6140 West Curtisian , Ste. 200
Boise, ID 83706
(801) 585-5122 University Hospital
Heart Failure Clinic
50 N Medical Dr
Salt Lake City, UT 84132
Map
(801) 585-3693 University Hospital
Heart Transplant Clinic
50 N Medical Dr
Salt Lake City, UT 84132
Map
(801) 584-1235 Veterans Administration Medical Center
500 S Foothill Blvd
Salt Lake City, UT 84149

Bio

Josef Stehlik, MD, MPH is an Associate Professor of Medicine at the University of Utah School of Medicine. Dr. Stehlik has received his medical degree from Charles University in Prague and Masters in Public Health degree from Harvard School of Public Health. He completed his training in Internal Medicine and in Cardiovascular Diseases at Allegheny General Hospital, MCP*Hahnemann University and advanced training in Heart Failure and Transplantation at the Cleveland Clinic.

Dr. Stehlik has been on faculty at the University of Utah since 2004 and serves as Medical Director of the Heart Transplant Program at the University of Utah Hospital and the Salt Lake City Veterans Affairs Medical Center. He has been active in clinical work, education and research in the areas of advanced heart failure, heart transplantation and mechanical circulatory support.

Board Certification and Academic Information

Academic Departments Internal Medicine - Associate Professor
Academic Divisions Cardiovascular Medicine
Board Certification American Board of Internal Medicine (Sub: Advanced Heart Failure & Transplant Cardiology)
Certification Board of Nuclear Cardiology

Patient Ratings

The Patient Rating score is an average of all responses to care provider related questions on our nationally-recognized Press Ganey Patient Satisfaction Survey.

Responses are measured on a scale of 1 to 5 with 5 being the best score.

Likelihood of recommending care provider
4.6
My confidence in care provider
4.6
Time care provider spent with me
4.5
Care provider spoke using clear language
4.6
Care provider's effort to include me in decisions
4.6
Care provider's concern for questions & worries
4.5
Care provider's explanation of condition/problem
4.5
Wait time at clinic
3.9
Care provider's friendliness and courtesy
4.7

Patient Comments

Patient comments are gathered from our Press Ganey Patient Satisfaction Survey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.

July 02, 2014

I had a different doctor this visit. I was confused by his questions asking me exactly what I want him to do for me. I have been under the care of this office for almost a year and felt we were treating my cardio condition. I am not the professional. I have no idea what is needed to treat it.

May 12, 2014

spent a lot more time with the assistant than the actual doctor.

March 25, 2013

excellent

March 04, 2013

I felt that confident that, the providers had my well being, as a major concern.

December 30, 2012

I had good care from both Dr Stehlik and Dr 'Blake'. Dr 'Blake' went out of her way to help answer some questions I had regarding options for my upcoming surgery

December 04, 2012

The primary doctor seems too rushed and disinterested. The other staff are great.

Academic Profile

Board Certification and Academic Information

Academic Departments Internal Medicine - Associate Professor
Academic Divisions Cardiovascular Medicine
Board Certification American Board of Internal Medicine (Sub: Advanced Heart Failure & Transplant Cardiology)
Certification Board of Nuclear Cardiology

Academic Office Locations

Academic Office Phone Number Academic Office Address
(801) 585-2340 School of Medicine
Division of Cardiovascular Medicine
30 N Medical Dr
Salt Lake City, UT 84132
Veterans Administration Medical Center
500 S Foothill Blvd
Salt Lake City, UT 84149

Academic Bio

Josef Stehlik, MD, MPH is an Associate Professor of Medicine with tenure at the University of Utah School of Medicine. Dr. Stehlik has received his medical degree from Charles University in Prague and Masters in Public Health degree from Harvard School of Public Health. He completed his training in Internal Medicine and in Cardiovascular Diseases at Allegheny General Hospital, MCP*Hahnemann University and advanced training in Heart Failure and Transplantation at the Cleveland Clinic.

Dr. Stehlik serves as Medical Director of the Heart Transplant Program at the University of Utah Hospital and the Salt Lake City Veterans Affairs Medical Center.

Dr. Stehlik has been active in clinical work, education and research in the areas of advanced heart failure, heart transplantation and mechanical circulatory support. He has received research funding from the American Heart Association, the Veterans Health Administration and the National Institutes of Health. He is an author of over 70 peer-reviewed articles and has authored a number of book chapters.

In 2012, Dr. Stehlik has been appointed Director of the International Society for Heart and Lung Transplantation Scientific Registry.

Selected publications:

- Hammond ME, Stehlik J, Snow G, Renlund DG, Seaman J, Dabbas B, Gilbert EM, Stringham JC, Long JW, Kfoury AG. Utility of histologic parameters in screening for antibody-mediated rejection of the cardiac allograft: a study of 3,170 biopsies.. J Heart Lung Transplant. 2005 Dec;24(12):2015-21.

- Kfoury AG, Stehlik J, Renlund, DG; Snow G, Seaman JT, Gilbert EM, Stringham JS, Long JW, Hammond ME: The Impact Of Repetitive Episodes Of Antibody-Mediated Or Cellular Rejection On Cardiovascular Mortality In Cardiac Transplant Recipients: Defining Rejection Patterns; J Heart Lung Transplant; 2006 Nov;25(11):1277-82. Epub 2006 Oct 16.

- Stehlik J, Starling R, Movsesian M, Fang J, Brown R, Jessup M, Hess M, Lewis N, Kirklin J. Utility of long-term surveillance endomyocardial biopsy. A multi-institutional analysis. J Heart Lung Transplant 2006 Dec;25(12):1402-9.

- Rasmusson KD, Stehlik J, Brown RN, Renlund DG, Wagoner LE, Torre-Amione G, Folsom JW, Silber DH, Kirklin JK: Long-Term Outcomes of Transplantation for Peripartum Cardiomyopathy. A Multi-institutional Analysis. J Heart Lung Transplant. 2007 Nov; 26(11):1097-104.

- Stehlik J, Movsesian MA. Combined use of PDE5 inhibitors and nitrates in the treatment of pulmonary arterial hypertension in patients with heart failure.

Journal of Cardiac Failure. J Card Fail. 2009 Feb;15(1):31-4. Epub 2008 Nov 5.

- Stehlik J, Nelson D, Kfoury AG, Reid BB, Clayson SE, Nelson KE, Christensen BJ, Renlund DG, Movsesian MA, Cowley CG, Smith HK, Rasmusson BY, Long JW. Outcome of Non-cardiac Surgery in Patients with Ventricular Assist Devices. Am J Cardiol. 2009 Mar 1;103(5):709-12. Epub 2009 Jan 15.

- Rogers RK, Stoddard GJ, Greene T, Michaels AD, Fernandez G, Freeman A, Nord J, Stehlik J. Usefulness of adjusting for clinical covariates to improve the ability of B-type natriuretic peptide to distinguish cardiac from noncardiac dyspnea. Am J Cardiol. 2009 Sep 1;104(5):689-94. Epub 2009 Jun 24.

- Stehlik J, Islam N, Hurst D, Kfoury AG, Movsesian MA, Fuller A, Delgado JC, Hammond MEH, Gilbert EM, Renlund DG, Bader F, Fisher PW, Bull DA, Singhal AK, Eckels DD. Utility of Virtual Crossmatch in Sensitized Patients Awaiting Heart Transplantation. J Heart Lung Transplant. 2009 Nov; 28(11):1129-34. Epub 2009 Sep 26.

- Nativi JN, Kfoury AG, Myrick C, Peters M, Renlund DG, Gilbert EM, Bader F, Singhal AK, Everitt M, Fisher PW, Bull, DA, Selzman C, Stehlik J. Effects of the 2006 U.S. Thoracic Organ Allocation Change: Analysis of Local Impact on Organ Procurement and Heart Transplantation. J Heart Lung Transplant. 2010 Mar;29(3):235-9. Epub 2009 Sep 26.

- Stehlik J, Feldman DS, Brown RN, Vanbakel AB, Russel SD, Ewald GA, Hagan ME, Folsom J, Kirklin JK; Cardiac Transplant Research Database Group. Interactions Among Donor Characteristics Influence Post-transplant Survival: A Multi-institutional Analysis. J Heart Lung Transplant. 2010 Mar; 29(3):291-8. Epub 2009 Oct 4.

- Movsesian MA, Stehlik J, Vandeput F, Bristow MR. Phosphodiesterase inhibition in heart failure. Heart Fail Rev. 2009 Dec;14(4):255-63. Epub 2008 Dec 19

- Rogers RK, Stehlik J, Stoddard G, Green T, Collins SP, Peacock WF, Maisel AD, Clopton P, Michaels AD. Adjusting for Clinical Covariates Improves the Ability of BNP to Distinguish Cardiac from Non-Cardiac Dyspnea: A Sub-Study of HEARD-IT. Eur J Heart Fail. 2009 Nov;11(11):1043-9. Epub 2009 Oct 6.

- Nativi JN, Brown RN, Taylor DO, Kfoury AG, Kirklin JK, Stehlik J. Temporal Trends in Heart Transplantation from High-Risk Donors: Are there lessons to be learned? A Multi-institutional Analysis. J Heart Lung Transplant. 2010 Aug;29(8):847-52. Epub 2010 May 20.

- Drakos SG, Kfoury AG, Hammond EH, Reid BB, Revelo MP, Rasmusson BY, Whitehead KJ, Salama M, Selzman CH, Stehlik J, Clayson S, Bristow MR, Renlund DG, Li DY. Impact of Mechanical Unloading on Microvasculature and Associated Central Remodeling Features of the Failing Human Heart. J Am Coll Cardiol. 2010 Jul 27;56(5):382-391

- Hayman MA, Nativi JN, Stehlik J, McDaniel J, Fjeldstad AS, Ives SJ, Wray DW, Bader F, Gilbert EM, Richardson RS. Understanding Exercise-induced Hyperemia: Central and Peripheral Hemodynamic Responses to Passive Limb Movement in Heart Transplant Recipients. Am J Physiol Heart Circ Physiol. 2010 Sep 10. 2010 Nov;299(5):H1653-9. Epub 2010 Sep 10.

- Revelo MP, Stehlik J, Miller D, Snow GL, Everitt MD, Budge D, Bader FM, Alharethi RA, Gilbert EM, Reid BB, Selzman CH, Hammond ME, Kfoury AG. Antibody testing for cardiac antibody-mediated rejection: Which panel correlates best with cardiovascular death? J Heart Lung Transplant. 2011 Feb;30(2):144-50. Epub 2010 Sep 19

- Stehlik J, Edwards LB, Kucheryavaya AY, Aurora P, Christie JD, Kirk R, Dobbels F, Rahmel AO, Hertz MI. The Registry of the International Society for Heart and Lung Transplantation: Twenty-seventh official adult heart transplant report-2010.

J Heart Lung Transplant. 2010 Oct;29(10):1089-1103.

- Costanzo MR et al. The international society of heart and lung transplantation guidelines for the care of heart transplant recipients. J Heart Lung Transplant. 2010 Aug;29(8):914-956.

- Nativi JN, Drakos SG, Kucheryavaya AY, Edwards LB, Selzman CH, Taylor DO, Hertz MI, Kfoury AG, Stehlik J. Changing outcomes in patients bridged to heart transplantation with continuous- versus pulsatile-flow ventricular assist devices: An analysis of the registry of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant. 2011 Apr;30(4):395-401. Epub 2010 Oct 29.

- Horne BD, Rasmusson KD, Alharethi R, Budge D, Brunisholz KD, Metz T, Carlquist JF, Connolly JJ, Porter TF, Lappé DL, Muhlestein JB, Silver R, Stehlik J, Park JJ, May HT, Bair TL, Anderson JL, Renlund DG, Kfoury AG. Genome-wide significance and replication of the chromosome 12p11.22 locus near the PTHLH gene for peripartum cardiomyopathy. Circ Cardiovas Genet. 2011 Aug 1;4(4):359-66. Epub 2011 Jun 10.

- Pinzon OW, Stoddard G, Drakos SG, Gilbert EM, Nativi JN, Budge D, Bader F, Alharethi R, Reid B, Selzman CH, Everitt MD, Kfoury AG, Stehlik J. Impact of Donor Left Ventricular Hypertrophy on Survival After Heart Transplant. Am J Transplant. 2011 Dec;11(12):2755-61. Epub 2011 Sep 11.

- Drakos SG, Kfoury AG, Selzman CH, Verma DR, Nanas JN, Li DY, Stehlik J. Left ventricular assist device unloading effects on myocardial structure and function: current status of the field and call for action. Curr Opin Cardiol. 2011 May;26(3):245-55.

- Stehlik J, Feldman DS. 2011-2020: Decade of the ventricular assist device. Curr Opin Cardiol. 2011 May;26(3):230-1.

- Stehlik J, Edwards LB, Kucheryavaya AY, Benden C, Christie JD, Dobbels F, Kirk R, Rahmel AO, Hertz MI. The Registry of the International Society for Heart and Lung Transplantation: Twenty-eighth Adult Heart Transplant Report-2011. J Heart Lung Transplant. 2011 Oct;30(10):1078-94.

- Wever-Pinzon O, Stehlik J, Kfoury AG, Terrovitis JV, Diakos NA, Charitos C, Li DY, Drakos SG. Ventricular assist devices: Pharmacological aspects of a mechanical therapy. Pharmacol Ther. 2012 May;134(2):189-99. Epub 2012 Jan 16.

- Oliveira GH, Hardaway BW, Kucheryavaya AY, Stehlik J, Edwards LB, Taylor DO.

Characteristics and survival of patients with chemotherapy-induced cardiomyopathy undergoing heart transplantation. J Heart Lung Transplant. 2012 Aug;31(8):805-10. Epub 2012 May 1.

- Witman MA, Fjeldstad AS, McDaniel J, Ives SJ, Zhao J, Barrett-O'Keefe Z, Nativi JN, Stehlik J, Wray DW, Richardson RS. Vascular Function and the Role of Oxidative Stress in Heart Failure, Heart Transplant, and Beyond. Hypertension. 2012 Jul 2.

- Drakos SG, Kfoury AG, Stehlik J, Selzman CH, Reid BB, Terrovitis JV, Nanas JN, Li DY. Bridge to recovery: understanding the disconnect between clinical and biological outcomes. Circulation. 2012 Jul 10;126(2):230-41.

Education

Education History

Type School Degree
Fellowship Cleveland Clinic Foundation
Heart Failure and Cardiac Transplant
Fellow
Graduate Training Harvard School of Public Health
Public Health
M.P.H.
Fellowship Allegheny General Hospital, MCP Hahnemann University
Cardiology
Fellow
Residency Allegheny General Hospital, MCP Hahnemann University
Internal Medicine
Resident
Internship Allegheny General Hospital
Internal Medicine
Intern
Professional Medical Charles University
Medicine
M.D.

Publications

Selected Provider Publications

Journal Article

  1. Wever-Pinzon O, Drakos SG, Kfoury AG, Nativi JN, Gilbert EM, Everitt M, Alharethi R, Brunisholz K, Bader FM, Li DY, Selzman CH, Stehlik J (2013). Morbidity and mortality in heart transplant candidates supported with mechanical circulatory support: is reappraisal of the current United network for organ sharing thoracic organ allocation policy justified? Circulation, 127(4), 452-62.
  2. Stehlik J, Edwards LB, Rowe A, Philibin K, Williamson J, Kirklin JK, Taylor DO, Hertz MI (2013). ISHLT International Registry for Heart and Lung Transplantation - three decades of scientific contributions. Transplant Rev (Orlando), 27(2), 38-42.
  3. Wever-Pinzon O, Selzman CH, Drakos SG, Saidi A, Stoddard GJ, Gilbert EM, Labedi M, Reid BB, Davis ES, Kfoury AG, Li DY, Stehlik J, Bader F (2013). Pulsatility and the risk of nonsurgical bleeding in patients supported with the continuous-flow left ventricular assist device HeartMate II. Circ Heart Fail, 6(3), 517-26.
  4. Drakos SG, Wever-Pinzon O, Selzman CH, Gilbert EM, Alharethi R, Reid BB, Saidi A, Diakos NA, Stoker S, Davis ES, Movsesian M, Li DY, Stehlik J, Kfoury AG (2013). Magnitude and time course of changes induced by continuous-flow left ventricular assist device unloading in chronic heart failure: insights into cardiac recovery. J Am Coll Cardiol, 61(19), 1985-94.
  5. Kfoury AG, Snow GL, Budge D, Alharethi RA, Stehlik J, Everitt MD, Miller DV, Drakos SG, Reid BB, Revelo MP, Gilbert EM, Selzman CH, Bader FM, Connelly JJ, Hammond ME (2012). A longitudinal study of the course of asymptomatic antibody-mediated rejection in heart transplantation. J Heart Lung Transplant, 31(1), 46-51.
  6. Wever-Pinzon O, Stehlik J, Kfoury AG, Terrovitis JV, Diakos NA, Charitos C, Li DY, Drakos SG (2012). Ventricular assist devices: Pharmacological aspects of a mechanical therapy. Pharmacol Ther, 134(2), 189-99.
  7. Stehlik J, Labedi M, Miller D, Revelo MP (2012). Abnormal finding on a screening endomyocardial biopsy. Am J Transplant, 12(2), 500; quiz 499, 501.
  8. Rasmusson K, Brunisholz K, Budge D, Horne BD, Alharethi R, Folsom J, Connolly JJ, Stehlik J, Kfoury A (2012). Peripartum cardiomyopathy: post-transplant outcomes from the United Network for Organ Sharing Database. J Heart Lung Transplant, 31(2), 180-6.
  9. Revelo MP, Miller DV, Stehlik J, Brunisholz K, Drakos S, Gilbert EM, Everitt M, Budge D, Alharethi R, Snow G, Hammond EH, Kfoury AG (2012). Longitudinal evaluation of microvessel density in survivors vs. nonsurvivors of cardiac pathologic antibody-mediated rejection. Cardiovasc Pathol.
  10. Oliveira GH, Hardaway BW, Kucheryavaya AY, Stehlik J, Edwards LB, Taylor DO (2012). Characteristics and survival of patients with chemotherapy-induced cardiomyopathy undergoing heart transplantation. J Heart Lung Transplant.
  11. Everitt MD, Hammond ME, Snow GL, Stehlik J, Revelo MP, Miller DV, Kaza AK, Budge D, Alharethi R, Molina KM, Kfoury AG (2012). Biopsy-diagnosed antibody-mediated rejection based on the proposed International Society for Heart and Lung Transplantation working formulation is associated with adverse cardiovascular outcomes after pediatric heart transplant. J Heart Lung Transplant.
  12. Drakos SG, Kfoury AG, Stehlik J, Selzman CH, Reid BB, Terrovitis JV, Nanas JN, Li DY (2012). Bridge to recovery: understanding the disconnect between clinical and biological outcomes. Circulation, 126(2), 230-41.
  13. Nativi JN, Drakos SG, Kucheryavaya AY, Edwards LB, Selzman CH, Taylor DO, Hertz MI, Kfoury AG, Stehlik J (2011). Changing outcomes in patients bridged to heart transplantation with continuous- versus pulsatile-flow ventricular assist devices: an analysis of the registry of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant, 30(8), 854-61.
  14. Pinzon OW, Stoddard G, Drakos SG, Gilbert EM, Nativi JN, Budge D, Bader F, Alharethi R, Reid B, Selzman CH, Everitt MD, Kfoury AG, Stehlik J (2011). Impact of Donor Left Ventricular Hypertrophy on Survival After Heart Transplant.LID - 10.1111/j.1600-6143.2011.03744.x [doi]. Am J Transplant.
  15. Healy AH, Mason NO, Hammond ME, Reid BB, Clayson SE, Drakos SG, Kfoury AG, Patel AN, Bull DA, Budge D, Alharethi RA, Bader FM, Gilbert EM, Stehlik J, Selzman CH (2011). Allograft rejection in patients supported with continuous-flow left ventricular assist devices. Ann Thorac Surg, 92(5), 1601-7; discussion 1607.
  16. Stehlik J, Edwards LB, Kucheryavaya AY, Benden C, Christie JD, Dobbels F, Kirk R, Rahmel AO, Hertz MI (2011). The Registry of the International Society for Heart and Lung Transplantation: Twenty-eighth Adult Heart Transplant Report--2011. J Heart Lung Transplant, 30(10), 1078-94.
  17. Costanzo MR, Costanzo MR, Dipchand A, Starling R, Anderson A, Chan M, Desai S, Fedson S, Fisher P, Gonzales-Stawinski G, Martinelli L, McGiffin D, Smith J, Taylor D, Meiser B, Webber S, Baran D, Carboni M, Dengler T, Feldman D, Frigerio M, Kfoury A, Kim D, Kobashigawa J, Shullo M, Stehlik J, Teuteberg J, Uber P, Zuckermann A, Hunt S, Burch M, Bhat G, Canter C, Chinnock R, Crespo-Leiro M, Delgado R, Dobbels F, Grady K, Kao W, Lamour J, Parry G, Patel J, Pini D, Towbin J, Wolfel G, Delgado D, Eisen H, Goldberg L, Hosenpud J, Johnson M, Keogh A, Lewis C, OConnell J, Rogers J, Ross H, Russell S, Vanhaecke J (2010). The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients. J Heart Lung Transplant, 29(8), 914-56.
  18. Drakos SG, Kfoury AG, Hammond EH, Reid BB, Revelo MP, Rasmusson BY, Whitehead KJ, Salama ME, Selzman CH, Stehlik J, Clayson SE, Bristow MR, Renlund DG, Li DY (2010). Impact of mechanical unloading on microvasculature and associated central remodeling features of the failing human heart. J Am Coll Cardiol, 56(5), 382-91.
  19. Hayman MA, Nativi JN, Stehlik J, McDaniel J, Fjeldstad AS, Ives SJ, Walter Wray D, Bader F, Gilbert EM, Richardson RS (2010). Understanding exercise-induced hyperemia: central and peripheral hemodynamic responses to passive limb movement in heart transplant recipients. Am J Physiol Heart Circ Physiol, 299(5), H1653-9.
  20. Revelo MP, Stehlik J, Miller D, Snow GL, Everitt MD, Budge D, Bader FM, Alharethi RA, Gilbert EM, Reid BB, Selzman CH, Hammond ME, Kfoury AG (2010). Antibody testing for cardiac antibody-mediated rejection: Which panel correlates best with cardiovascular death? J Heart Lung Transplant.
  21. Stehlik J, Edwards LB, Kucheryavaya AY, Aurora P, Christie JD, Kirk R, Dobbels F, Rahmel AO, Hertz MI (2010). The Registry of the International Society for Heart and Lung Transplantation: twenty-seventh official adult heart transplant report--2010. J Heart Lung Transplant, 29(10), 1089-103.
  22. Everitt MD, Donaldson AE, Stehlik J, Kaza AK, Budge D, Alharethi R, Bullock EA, Kfoury AG, Yetman AT (2010). Would access to device therapies improve transplant outcomes for adults with congenital heart disease? Analysis of the United Network for Organ Sharing (UNOS). J Heart Lung Transplant.
  23. Kfoury AG, Renlund DG, Snow GL, Stehlik J, Folsom JW, Fisher PW, Reid BB, Clayson SE, Gilbert EM, Everitt MD, Bader FM, Singhal AK, Hammond ME (2009). A clinical correlation study of severity of antibody-mediated rejection and cardiovascular mortality in heart transplantation. J Heart Lung Transplant, 28(1), 51-7.
  24. Rasmusson KD, Stehlik J, Brown RN, Renlund DG, Wagoner LE, Torre-Amione G, Folsom JW, Silber DH, Kirklin JK (2007). Long-term outcomes of cardiac transplantation for peri-partum cardiomyopathy: a multiinstitutional analysis. J Heart Lung Transplant, 26(11), 1097-104.
  25. Kfoury AG, Hammond ME, Snow GL, Stehlik J, Reid BB, Long JW, Gilbert EM, Bader FM, Bull DA, Renlund DG (2007). Early screening for antibody-mediated rejection in heart transplant recipients. J Heart Lung Transplant, 26(12), 1264-9.
  26. Kfoury AG, Stehlik J, Renlund DG, Snow G, Seaman JT, Gilbert EM, Stringham JS, Long JW, Hammond ME (2006). Impact of repetitive episodes of antibody-mediated or cellular rejection on cardiovascular mortality in cardiac transplant recipients: defining rejection patterns. J Heart Lung Transplant, 25(11), 1277-82.
  27. Stehlik J, Starling RC, Movsesian MA, Fang JC, Brown RN, Hess ML, Lewis NP, Kirklin JK (2006). Utility of long-term surveillance endomyocardial biopsy: a multi-institutional analysis. J Heart Lung Transplant, 25(12), 1402-9.

Review

  1. Drakos SG, Kfoury AG, Selzman CH, Verma DR, Nanas JN, Li DY, Stehlik J (2011). Left ventricular assist device unloading effects on myocardial structure and function: current status of the field and call for action. [Review]. Curr Opin Cardiol, 26(3), 245-55.

Case Report

  1. Selzman CH, Desjardins G, Patel AN, Davis E, Dick S, Stehlik J (2012). Complications associated with the use of left ventricular assist device therapy in an adult patient with Ebstein's anomaly. Ann Thorac Surg, 93(1), 297-9.

Editorial

  1. Stehlik J, Feldman DS (2011). 2011-2020: decade of the ventricular assist device. Curr Opin Cardiol, 26(3), 230-1.

Clinical Trials

Video & News

Video